OpenEvidence Soars: 'ChatGPT for Doctors' Secures $12B Valuation!

business #llm 📝 Blog|Analyzed: Jan 21, 2026 13:02•

Published: Jan 21, 2026 13:00

•

1 min read

Analysis

OpenEvidence, the innovative company building "ChatGPT for doctors," has secured a massive $12 billion valuation in its latest funding round. This rapid growth, significantly up from its October valuation, signals tremendous investor confidence in the future of AI-powered healthcare and its potential to revolutionize the medical field!

Key Takeaways

•OpenEvidence, the company behind "ChatGPT for doctors," raised $250 million in a new funding round.
•The company's valuation has skyrocketed to $12 billion, demonstrating significant growth since October.
•The funding round was led by Thrive and DST, highlighting investor confidence in AI's medical applications.

Reference / Citation

View Original

"OpenEvidence, which is building “ChatGPT for doctors”, raised $250M led by Thrive and DST at a $12B valuation, up from $6B in October and $1B in February 2025"

TechmemeJan 21, 2026 13:00

* Cited for critical analysis under Article 32.

Older

Premiere Pro Revamps Editing with Exciting AI Power!

Newer

AI-Powered Geothermal: Zanskar Secures $115M to Unlock Clean Energy Potential